Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $9.60, but opened at $11.38. Veradigm shares last traded at $11.25, with a volume of 55,507 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, StockNews.com assumed coverage on Veradigm in a research note on Saturday, November 9th. They issued a “hold” rating on the stock. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $12.00.
Read Our Latest Analysis on Veradigm
Veradigm Stock Up 0.4 %
Hedge Funds Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new stake in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Where to Find Earnings Call Transcripts
- Insiders Bet Big on These Small Cap Stocks
- Quiet Period Expirations Explained
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- There Are Different Types of Stock To Invest In
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.